I

Inoviv

23 employees

Accelerating the world’s transition to precision medicine through application of omics technologies to drug development and healthcare.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical Device
Health Diagnostics
Health Care
Therapeutics
Medical
Biopharma

Date founded

2017

Funding rounds raised

I

Inoviv raised undisclosed on June 6, 2021

Investors: Hoxton Ventures and Ada Ventures

I

Inoviv raised undisclosed on January 1, 2017

Investors: Hoxton Ventures

FAQ